Skip to content

Active ingredient

Sildenafil

234 finished FDA listings contain Sildenafil as their only active ingredient.

At a glance

From the FDA NDC Directory

Ingredient names as written by FDA
SILDENAFIL, SILDENAFIL CITRATE
Dosage forms
Film, For Suspension, Injection, Solution, Powder, For Suspension, Tablet, Tablet, Film Coated
Routes
Intravenous, Oral
Manufacturers / labelers
65
Strengths listed
.8 mg/ml · 10 mg/12.5ml · 10 mg/ml · 100 mg/1 · 20 mg/1 · 25 mg/1 · 50 mg/1 · 75 mg/1
Brand names in FDA listings
Revatio, Sildenafil, Sildenafil Citrate, Viagra, Vybrique

Official drug information

Source coverage for Sildenafil:

  • FDA NDC Directory: linked
  • RxNorm: linked
  • Drugs@FDA: linked
  • DailyMed: linked

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 136411

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

  • Application
    NDA 020895
    Sponsor
    VIATRIS
    Original approval
    1998-03-27
    Listings
    9
  • Application
    NDA 021845
    Sponsor
    VIATRIS
    Original approval
    2005-06-03
    Listings
    2
  • Application
    NDA 022473
    Sponsor
    VIATRIS
    Original approval
    2009-11-18
    Listings
    1
  • Application
    NDA 203109
    Sponsor
    VIATRIS
    Original approval
    2012-08-30
    Listings
    1
  • Application
    ANDA 091479
    Sponsor
    TORRENT PHARMS LTD
    Original approval
    2012-11-06
    Listings
    9
  • Application
    ANDA 202598
    Sponsor
    CHARTWELL RX
    Original approval
    2012-11-06
    Listings
    1
  • Application
    ANDA 078380
    Sponsor
    TEVA PHARMS
    Original approval
    2013-01-07
    Listings
    1
  • Application
    ANDA 202025
    Sponsor
    AMNEAL PHARMS
    Original approval
    2013-02-28
    Listings
    9
  • Application
    ANDA 203814
    Sponsor
    MACLEODS PHARMS
    Original approval
    2013-12-17
    Listings
    12
  • Application
    ANDA 203623
    Sponsor
    HETERO LABS LTD V
    Original approval
    2014-11-26
    Listings
    7
  • Application
    ANDA 203988
    Sponsor
    EUGIA PHARMA
    Original approval
    2015-04-01
    Listings
    1
  • Application
    ANDA 203963
    Sponsor
    AUROBINDO PHARMA LTD
    Original approval
    2015-11-18
    Listings
    2
  • Application
    ANDA 077342
    Sponsor
    TEVA
    Original approval
    2016-03-09
    Listings
    6
  • Application
    ANDA 204883
    Sponsor
    RUBICON RESEARCH
    Original approval
    2016-06-20
    Listings
    6
  • Application
    ANDA 210394
    Sponsor
    AJANTA PHARMA LTD
    Original approval
    2018-05-04
    Listings
    9
  • Application
    ANDA 204882
    Sponsor
    RUBICON RESEARCH
    Original approval
    2018-06-11
    Listings
    7
  • Application
    ANDA 091448
    Sponsor
    TORRENT
    Original approval
    2018-06-11
    Listings
    12
  • Application
    ANDA 203962
    Sponsor
    AUROBINDO PHARMA LTD
    Original approval
    2018-06-11
    Listings
    10
  • Application
    ANDA 202659
    Sponsor
    HETERO LABS LTD V
    Original approval
    2018-06-11
    Listings
    25
  • Application
    ANDA 202023
    Sponsor
    AMNEAL PHARMS NY
    Original approval
    2018-06-27
    Listings
    6
  • Application
    ANDA 206401
    Sponsor
    AJANTA PHARMA LTD
    Original approval
    2018-10-12
    Listings
    18
  • Application
    ANDA 211092
    Sponsor
    AMNEAL PHARMS
    Original approval
    2019-11-27
    Listings
    2
  • Application
    ANDA 212883
    Sponsor
    AJANTA PHARMA LTD
    Original approval
    2019-11-27
    Listings
    1
  • Application
    ANDA 207178
    Sponsor
    APPCO
    Original approval
    2020-03-02
    Listings
    12
  • Application
    ANDA 211534
    Sponsor
    TEVA PHARMS USA
    Original approval
    2020-05-29
    Listings
    1
  • Application
    ANDA 213032
    Sponsor
    SUNSHINE
    Original approval
    2020-06-11
    Listings
    3
  • Application
    ANDA 208494
    Sponsor
    REYOUNG
    Original approval
    2020-06-12
    Listings
    6
  • Application
    ANDA 209302
    Sponsor
    UMEDICA
    Original approval
    2020-08-25
    Listings
    19
  • Application
    ANDA 213814
    Sponsor
    CHARTWELL RX
    Original approval
    2021-04-29
    Listings
    1
  • Application
    ANDA 213014
    Sponsor
    HETERO LABS LTD V
    Original approval
    2021-05-11
    Listings
    1
  • Application
    ANDA 214641
    Sponsor
    MSN
    Original approval
    2022-02-08
    Listings
    1
  • Application
    ANDA 211638
    Sponsor
    LUPIN
    Original approval
    2022-03-23
    Listings
    1
  • Application
    ANDA 215708
    Sponsor
    ZYDUS LIFESCIENCES
    Original approval
    2022-09-29
    Listings
    2
  • Application
    ANDA 214773
    Sponsor
    AUROBINDO PHARMA LTD
    Original approval
    2022-12-23
    Listings
    1
  • Application
    ANDA 202255
    Sponsor
    MACLEODS PHARMS
    Original approval
    2023-04-19
    Listings
    5
  • Application
    ANDA 216383
    Sponsor
    NOVITIUM PHARMA
    Original approval
    2023-08-29
    Listings
    3
  • Application
    ANDA 218045
    Sponsor
    CADILA PHARMS LTD
    Original approval
    2023-11-28
    Listings
    6
  • Application
    ANDA 201156
    Sponsor
    JUBILANT GENERICS
    Original approval
    2024-12-20
    Listings
    3
  • Application
    ANDA 202954
    Sponsor
    JUBILANT GENERICS
    Original approval
    2025-03-06
    Listings
    2
  • Application
    NDA 210858
    Sponsor
    IBSA
    Original approval
    2025-12-16
    Listings
    8

Showing 40 of 42 applications.

Official labeling on DailyMed

Showing the 12 most recent of 165 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.